Parent-reported activity and health-related quality of life after botulinum toxin in spastic cerebral palsy
Acta Orthopaedica et Traumatologica Turcica · 16.04.2026 · 60 (2)
DOI: 10.5152/j.aott.2026.25612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, online erschienen am 16.04.2026. Verfasst von Geylanur Kaya Yavuz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Giresun Physical Therapy and Rehabilitation Center Pediatric Rehabilitation Clinic, Giresun, Türkiye. Hauptthemen laut MEDLINE: Cerebral Palsy, Quality of Life, Parents, Muscle Spasticity. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to investigate changes in activity levels and health-related quality of life (HRQoL) in children with spastic cerebral palsy (CP) before and after botulinum toxin (BTX) injection, based on parental reports within the International Classification of Functioning Disability and Health (ICF) framework.
Methods
This retrospective study included 60 children with spastic CP (20 girls, 40 boys) who underwent BTX injection for spasticity management. The age range was 2-11 years (mean age, 5.44 Å} 2.09 years). Gross motor function level was classified using the Gross Motor Function Classification System–Family Report. Activity was evaluated with the Pediatric Outcome Data Collection Instrumen (PODCI), and HRQoL was assessed using the Pediatric Quality of Life Inventory (PedsQL) before and after BTX injection. Parents completed all questionnaires 6-12 months after BTX injection; pre- and post-injection scores were compared.
Results
The PODCI scores improved significantly after BTX in upper extremity function (P = .001), transfers/basic mobility (P = .005), pain/comfort (P = .009), happiness/satisfaction (P < .001), and global score (P < .001), while the physical function/sports subscale did not change significantly (P = .136). The PedsQL total score improved (P < .001), with significant improvements in daily activities (P < .001), school (P = .034), activity/balance (P < .001), pain/ache (P = .015), fatigue/prostration (P = .002), and nutrition (P = .027); the speech/communication domain showed no significant change (P = .150).
Conclusion
From a parental perspective, BTX injection was associated with improved activity and HRQoL in children with spastic CP, with gains seen across multiple functional and well-being domains. Clinically, these findings support counseling families that BTX within an ICF-oriented rehabilitation approach may translate into meaningful improvements in daily function and overall well-being, although speech-related outcomes may be less responsive. Cite this article as: Yavuz GK, Yılmaz G, Günel MK. Parent-reported activity and health-related quality of life after botulinum toxin in spastic cerebral palsy. Acta Orthop Traumatol Turc., 2026; 60(2), 0612, doi: 10.5152/j.aott.2026.25612.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Giresun Physical Therapy and Rehabilitation Center Pediatric Rehabilitation Clinic, Giresun, Türkiye.
- Department of Orthopaedics and Traumatology, Hacettepe University, Ankara, Türkiye.
- Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Türkiye.
Zitieren
APA
Kaya Yavuz, G., Yılmaz, G., & Kerem Günel, M. (2026). Parent-reported activity and health-related quality of life after botulinum toxin in spastic cerebral palsy. Acta Orthopaedica et Traumatologica Turcica, 60(2). https://doi.org/10.5152/j.aott.2026.25612
Vancouver
Kaya Yavuz G, Yılmaz G, Kerem Günel M. Parent-reported activity and health-related quality of life after botulinum toxin in spastic cerebral palsy. Acta Orthopaedica et Traumatologica Turcica. 2026;60(2). doi:10.5152/j.aott.2026.25612
BibTeX
@article{KayaYavuz2026,
author = {Kaya Yavuz, Geylanur and Yılmaz, Güney and Kerem Günel, Mintaze},
title = {Parent-reported activity and health-related quality of life after botulinum toxin in spastic cerebral palsy},
journal = {Acta Orthopaedica et Traumatologica Turcica},
year = {2026},
volume = {60},
number = {2},
doi = {10.5152/j.aott.2026.25612}
}
EUVIMED